Rigel Pharmaceuticals (RIGL) Capital Expenditures Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Rigel Pharmaceuticals | 551.62 Mn | 404.94 Mn | 54.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -15.14% |
| Dec 31, 2024 | -46.82% |
| Dec 31, 2022 | 6.61% |
| Sep 30, 2022 | 27.54% |
| Jun 30, 2022 | -35.52% |
| Mar 31, 2022 | 40.44% |
| Dec 31, 2021 | -40.63% |
| Sep 30, 2021 | -7.57% |
| Jun 30, 2021 | 12.59% |
| Mar 31, 2021 | -26.05% |
| Dec 31, 2020 | 30.34% |
| Sep 30, 2020 | -8.68% |
| Jun 30, 2020 | -21.08% |
| Mar 31, 2020 | 80.14% |
| Dec 31, 2019 | 25.03% |
| Sep 30, 2019 | 60.95% |
| Jun 30, 2019 | 8.92% |
| Mar 31, 2019 | 16.19% |
| Dec 31, 2018 | -16.30% |
| Sep 30, 2018 | 4.04% |
| Jun 30, 2018 | 22.40% |
| Mar 31, 2018 | -21.85% |
| Dec 31, 2017 | -38.47% |
| Sep 30, 2017 | -31.96% |
| Jun 30, 2017 | -55.67% |
| Mar 31, 2017 | -51.79% |
| Dec 31, 2016 | -49.63% |
| Sep 30, 2016 | -14.79% |
| Jun 30, 2016 | -20.24% |
| Mar 31, 2016 | -17.89% |
| Dec 31, 2015 | -32.09% |
| Sep 30, 2015 | -19.30% |